Vol. 9, Issue 1, Part A (2021)
Covid-19 pandemic: Scope of unani medicine with special reference to unani decoction for NazlaWabai
Author(s): Asim Ali Khan, Saad Ahmed, Shamim, Pawan Kumar and Shagufta Parveen
Abstract: Novel Coronavirus disease (COVID-19) caused by a newly discovered coronavirus continues to spread globally despite unprecedented social isolation and restrictions resulting in widespread economic decline. Most people infected with the COVID-19 virus experience mild to moderate respiratory illness and recover without requiring special treatment. However, older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. The COVID-19 virus spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. At present, there are no specific vaccines or treatments for COVID-19. However, there are many ongoing clinical trials evaluating potential treatments. In this paper, Covid-19 has been correlated with the NazlaWabai on the basis of description of symptoms specified in Unani classical literature and scope of Unani decoction comprising of Unnab (Ziziphusjujuba), Sapistan (Cordialatifolia) & Behidana (Cydoniaoblonga) has been explored.
How to cite this article:
Asim Ali Khan, Saad Ahmed, Shamim, Pawan Kumar, Shagufta Parveen. Covid-19 pandemic: Scope of unani medicine with special reference to unani decoction for NazlaWabai. Int J Herb Med 2021;9(1):34-36.